EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 10 October 2019

Blogs

Analysis: Would ‘Medicines for the Many’ lead to many medicines?
10 October 2019 - Richard Torbett

Guest blog from Richard Torbett of ABPI on medicines access and availability in the UK Read more

How big is the need for cross-border access to clinical trials?
10 October 2019 - Ingrid Klingmann

Patients with rare tumours and other rare diseases are particularly in need for treatment options. In some cases, these... Read more

Events

LifeTime meets industry
31 October 2019 (Basel, Switzerland)

LifeTime is developing a Roadmap that will show the path on how technology developments will be combined with disease... Read more

Connecting Healthcare Debate
05 November 2019 (Residence Palace, Rue de la Loi 175, 1000 Brussels)

Making connections can advance patient care and support the European economy at a time of significant change and challenge... Read more

Evidence-based expertise for better policy-making
08 November 2019 (Brussels)

Expert panel on effective ways of investing in health end of mandate conference Read more

Joint EFPIA & EFGCP Multi-Stakeholder Workshop on Paediatric Unmet Medical Needs
12 December 2019 (Amsterdam, The Netherlands)

The workshop will be the opportunity to exchange opinions and develop mutually acceptable criteria for joint and informed... Read more

What we are reading

In AI We Trust? The Future of Genomic Medicine
On 01 October 2019 (GEN)

High-performance precision medicine requires high-performance computing Read more

Review of Progress on Antimicrobial Resistance
On 08 October 2019 (Chatham House)

A startling lack of progress on critical recommendations to tackle AMR Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu